Christopher M. Jewell

Insider Reports History

Identity
Location
Gaithersburg, MD
SEC record
Reporting signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Christopher Jewell
SEC evidence
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Christopher M. Jewell:

Form 4 holding Chief Scientific Officer

Cartesian Therapeutics, Inc.

Security class
Common Stock
Shares / value
62,490
Estimated value
$201,843
Report date
10 Jan 2025
Price
$3.23
Ownership
Direct
Form 4 holding Chief Scientific Officer

Cartesian Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
67,432
Estimated value
$53,271
Report date
10 Jan 2025
Price
$0.7900
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Scientific Officer

Cartesian Therapeutics, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
47,400
Estimated value
Report date
02 Jan 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Christopher M. Jewell

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .